Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Severe
C. difficile
colitis refractory to medical therapy may require surgical intervention including subtotal colectomy. We initiated
an adjuvant intracolonic vancomycin (ICV) enema protocol for inpatients with severe
C. difficile
colitis and compared the response
in patients admitted from the community and nursing homes. A single hospital, retrospective chart review was performed on 47
consecutive patients with
C. difficile
colitis treated with ICV (1 gram in 500 cc normal saline q 6 h) from January 2007 through October
2009. Associations of patient characteristics with outcomes (response to ICV therapy, need for surgery, and mortality) were examined
with bivariate tests and multivariable logistic models adjusting for age, hypoalbuminemia, acidosis, and nursing home status. Overall, 37
of 47 patients (79%) survived after ICV therapy. Incomplete responders who had surgery were more likely to survive than those patients
who did not undergo subtotal colectomy (p<0.01). Seven of 9 patients who underwent surgery survived. Nursing home residence,
acidosis, and hypoalbuminemia were significantly associated with non-resolution in bivariate analysis (all p<0.01). Multivariable logistic
models confirmed that acidosis correlated with incomplete response to ICV (P=0.02), and older age correlated with death (P=0.04);
hypoalbuminemia correlated significantly with both incomplete response to ICV and death (P=0.04). Hypoalbuminemia is a major
predictor of poor response to ICV and death from severe
C. difficile
colitis. Early surgery should be considered for geriatric patients who
present with hypoalbuminemia and acidosis. In this discussion, we will review the current medical and surgical therapies for severe
C.
difficile
colitis.
Biography
Peter K. Kim, M.D., FACS completed his undergraduate studies magna cum laude in Biochemistry at Harvard College, M.D. with honors in research
at Weill Medical College of Cornell University, and his surgical training at the University of Pittsburgh and Mount Sinai Medical Center. He is presently
Assistant Professor of Surgery at Albert Einstein College of Medicine and Jacobi Medical Center in the Bronx, NY. He specializes his work in the
complex management of life-threatening surgical infections.
Relevant Topics
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals